100
Participants
Start Date
November 30, 2005
Primary Completion Date
March 31, 2006
Study Completion Date
March 31, 2006
Lornoxicam 8 mg
Lornoxicam 16 mg
Ketorolac 30 mg
Placebo
Advanced Clinical Research Institute, Anaheim
Lead Sponsor
POZEN
INDUSTRY